Reg. no. 5594008202 · Research and experimental development on biotechnology · SOLNA
Xpress Genomics AB is registered with the legal form Limited company, is based in SOLNA and is active in Research and experimental development on biotechnology. Revenue for 2025 was 25.4 MSEK.
Fiscal year ending 2025-12-31 · Amounts in SEK
Net revenue
25.4 MSEK
▼ −24%Operating result
11.5 MSEK
▼ −59%Net result
8.1 MSEK
▼ −64%Employees (annual report)
5
▲ +150%Total assets
29.8 MSEK
Equity
12.8 MSEK
Equity ratio
50.9 %
Profit margin
31.8 %
MSEK
Xpress Genomics AB reported a 23.5 % decline in net sales in 2025, to 25.4 MSEK. The operating margin for 2025 was 45.3 %, compared with 83.4 % a period earlier. The company’s operating margin of 45.3 % exceeded three quarters of the 302 comparable companies in its industry. With 5 employees, net sales corresponded to roughly 5.1 MSEK per employee in 2025.
Calculated by ArkivNord from filed annual reports. Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Per the signatures in the annual report for the fiscal year ending 2025-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
Xpress Genomics AB's reg. no. is 5594008202.
Xpress Genomics AB reported revenue of 25.4 MSEK for the fiscal year 2025.
Yes — Xpress Genomics AB reported a net profit of 8.1 MSEK for 2025.
Xpress Genomics AB had 5 employees as of the most recently reported period (2025).
Xpress Genomics AB is registered under Research and experimental development on biotechnology.
Xpress Genomics AB is based in SOLNA.
arkivnord